Dr. Reddy's Laboratories Limited (DRREDDY)

1,117.45

INR
+4.35(+0.39%)
As of March 4, 2025 5:53:00 AM

About Dr. Reddy's Laboratories Limited

Dr. Reddy's Laboratories Ltd. is a globally recognized pharmaceutical company specializing in the manufacturing and distribution of a wide array of therapeutic substances and active pharmaceutical ingredients (APIs). Established in 1984 and headquartered in Hyderabad, India, the company plays a significant role in the healthcare sector, striving to make affordable medicine accessible worldwide. Dr. Reddy's Laboratories engages in research, development, and commercialization of complex generics, biosimilars, and proprietary products for various therapeutic areas, including gastroenterology, oncology, pain management, and dermatology. The company holds a substantial international presence with distribution extending across the United States, Russia, Europe, and emerging markets. Its diverse product portfolio not only supports critical medical needs but also drives the global push towards accessible healthcare solutions. Dr. Reddy's Laboratories' commitment to compliance, quality, and innovation enhances its standing in the pharmaceutical industry, contributing significantly to its market influence and ensuring the provision of high-quality medications to a broad demographic.

RevenueLast 12 months
NA
+NA YoY
EBITDALast 12 months
NA
Price to Sales RatioTTM
2.99
Operating MarginLast 12 months
22.38
+2.5% quarterly YoY
Market Cap
93049.26 CrINR
Employees
27048
CEO
Mr. Erez Israeli M.B.A.
Website